HealthTree Foundation for Multiple Myeloma
6.08K subscribers
1:04:49
Upcoming Changes to Medicare for 2025
HealthTree Foundation for Multiple Myeloma
112 views • 1 day ago
58:05
Community and Academic Centers Working Together For Best Patient Outcomes
HealthTree Foundation for Multiple Myeloma
40 views • 1 day ago
1:25:51
Innovation in Blood Cancer
HealthTree Foundation for Multiple Myeloma
292 views • 1 day ago
4:13
"Taking Back Control Through Education": Cecily's Cancer Story
HealthTree Foundation for Multiple Myeloma
84 views • 9 days ago
55:56
Talquetamab Side Effect Management
HealthTree Foundation for Multiple Myeloma
267 views • 13 days ago
3:49
"My Myeloma Doesn't Define Me": Susana's Cancer Story
HealthTree Foundation for Multiple Myeloma
207 views • 3 weeks ago
4:00
"I Am Determined To Live": Andréa’s Cancer Story
HealthTree Foundation for Multiple Myeloma
557 views • 3 weeks ago
4:10
Real Cancer Stories: Janet Schurmann
HealthTree Foundation for Multiple Myeloma
563 views • 4 weeks ago
0:50
Janet Schurmann's Story
HealthTree Foundation for Multiple Myeloma
56 views • 4 weeks ago
1:05:41
Dietary Research in Blood Cancers: Exploring the Impact of a Plant-Based Diet
HealthTree Foundation for Multiple Myeloma
878 views • 1 month ago
56:35
Elranatamab: How it works, how it's being used, and how it compares to other bispecifics.
HealthTree Foundation for Multiple Myeloma
459 views • 1 month ago
57:45
Understanding MGUS, Its Progression Risks, and More
HealthTree Foundation for Multiple Myeloma
688 views • 1 month ago
56:12
Chair Yoga
HealthTree Foundation for Multiple Myeloma
183 views • 2 months ago
45:03
Out of Pocket Costs and How to Talk to Your Insurance About Them
HealthTree Foundation for Multiple Myeloma
148 views • 2 months ago
36:56
The Latest in Amyloidosis Care and Research with Morie Gertz, MD, Mayo Clinic
HealthTree Foundation for Multiple Myeloma
167 views • 2 months ago
5:57
Elranatamab (ELEREXFIO) trial updates from EHA 2024
HealthTree Foundation for Multiple Myeloma
227 views • 2 months ago
1:01:07
Creating a Risk Profile to Personalize Myeloma Care with Ola Landgren, MD, PhD, University of Miami
HealthTree Foundation for Multiple Myeloma
229 views • 2 months ago
5:34
Updates on Elrantamab and other myeloma specific BsAbs | Mohamad Mohty, MD, PhD, EHA 2024
HealthTree Foundation for Multiple Myeloma
287 views • 3 months ago
5:31
Frontline and CAR-T Cell Therapy for Multiple Myeloma | Xavier Leleu, MD, MSc, PhD | EHA 2024
HealthTree Foundation for Multiple Myeloma
307 views • 3 months ago
3:16
Benefit Study IsaRVd vs IsaRd NDMM TI | Xavier Leleu, MD, MSc, PhD | EHA 2024
HealthTree Foundation for Multiple Myeloma
119 views • 3 months ago
2:39
Ide-cel Without Front-Line ASCT: KARMMA-2 Cohort 2B | Xavier Leleu, MD, MSc, PhD, EHA 2024
HealthTree Foundation for Multiple Myeloma
105 views • 3 months ago
1:42:12
Virtual HealthTree Cure Tour Workshop With Our Founder & CEO Jenny Ahlstrom
HealthTree Foundation for Multiple Myeloma
249 views • 3 months ago
7:07
ASCO/EHA 2024 Myeloma Highlights | Ajai Chari, MD | EHA 2024
HealthTree Foundation for Multiple Myeloma
491 views • 3 months ago
4:32
Phase I Study Findings: anitocabtagene autoleucel for RRMM treatment | Binod Dhakal, MD | EHA 2024
HealthTree Foundation for Multiple Myeloma
128 views • 3 months ago
57:03
Handling Difficult Decisions and Conversations
HealthTree Foundation for Multiple Myeloma
252 views • 3 months ago
1:02:07
Is MRD Negativity the Goal of Myeloma Treatment?
HealthTree Foundation for Multiple Myeloma
1.3K views • 3 months ago
4:59
REAL-WORLD SCHEDULE DE-ESCALATION OF TECLISTAMAB IN PATIENTS WITH RRMM | Carlyn Tan, MD | EHA 2024
HealthTree Foundation for Multiple Myeloma
226 views • 3 months ago
3:44
CARTITUDE-4 Subgroup Analysis of Functional High-Risk Patients | Luciano Costa, MD | EHA 2024
HealthTree Foundation for Multiple Myeloma
244 views • 3 months ago
3:42
Mezigdomide, Tazemetostat, and Dex in RRMM: Results from CA057-003 | Luciano Costa, MD | EHA 2024
HealthTree Foundation for Multiple Myeloma
226 views • 3 months ago
2:29
MAJESTIC-1 Study -A Subgroup Analysis of High-risk Patients | Luciano Costa, MD | EHA2024
HealthTree Foundation for Multiple Myeloma
103 views • 3 months ago
Load More